Welcome to NTK Institute

All alendronate News

04/17/2014	The resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate (Bone)
04/11/2014	Fracture Risk Reduction with Denosumab in Japanese Postmenopausal Women and Men with Osteoporosis: Denosumab fracture Intervention RandomizEd placebo Controlled Trial (DIRECT) (J Clin Endocrinol Metab)
04/08/2014	Established and forthcoming drugs for the treatment of osteoporosis (Curr Opin Rheumatol)
04/03/2014	Use of strontium ranelate and risk of acute coronary syndrome: cohort study (Ann Rheum Dis)
04/01/2014	Alendronate-induced atypical bone fracture: evidence that the drug inhibits osteogenesis (J Clin Pharm Ther)
03/27/2014	External auditory canal and middle ear cholesteatoma and osteonecrosis in bisphosphonate-treated osteoporosis patients: a Danish national register-based cohort study and literature review (Osteoporos Int)
03/27/2014	Bone mass behavior after 1 year of different treatment strategies in prostate cancer patients subjected to androgen deprivation therapy (Rheumatol Int)
03/26/2014	The inhibition of RANK-ligand in the management of postmenopausal osteoporosis and related fractures: the role of denosumab (Gynecol Endocrinol)
03/24/2014	Change in arterial stiffness associated with monthly bisphosphonate treatment in women with postmenopausal osteoporosis (Menopause)
03/20/2014	Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate (Clin Rheumatol)
03/10/2014	Osteoanabolic effect of alendronate and zoledronate on bone marrow stromal cells (BMSCs) isolated from aged female osteoporotic patients and its implications for their mode of action in the treatment of age-related bone loss (Osteoporos Int)
03/10/2014	Alendronate, a bisphosphonate, increased upper and lower gastrointestinal bleeding: risk factor analysis from a nationwide population-based study (Osteoporos Int)
03/10/2014	Factors associated with bisphosphonate treatment failure in postmenopausal women with primary osteoporosis (Osteoporos Int)
03/07/2014	Incidence and risk of osteonecrosis of the jaw among the Taiwan osteoporosis population (Osteoporos Int)
02/18/2014	A closer look at the immediate trabecula response to combined parathyroid hormone and alendronate treatment (Bone)
01/10/2014	Differing Effects of Denosumab and Alendronate on Cortical and Trabecular Bone (Bone)
01/10/2014	Effects of Teriparatide on Cortical Histomorphometric Variables in Postmenopausal Women With or Without Prior Alendronate Treatment (Bone)
01/08/2014	A Surgeon's guide to advances in the pharmacological management of acute Charcot neuroarthropathy (Foot Ankle Surg)
12/20/2013	Update on Long-Term Treatment With Bisphosphonates for Postmenopausal Osteoporosis: A Systematic Review (Bone)
12/18/2013	Natural history and risk factors for adjacent vertebral fractures in the fracture intervention trial (Spine)
12/11/2013	The non-interventional BonViva Intravenous Versus Alendronate (VIVA) study: real-world adherence and persistence to medication, efficacy, and safety, in patients with postmenopausal osteoporosis (Osteoporos Int)
12/05/2013	Bisphosphonate long-term treatment related bilateral subtrochanteric femoral fracture. Can teriparatide be useful? (Aging Clin Exp Res)
12/05/2013	Early effects of parathyroid hormone on bisphosphonate/steroid-associated compromised osseous wound healing (Osteoporos Int)
12/03/2013	Comparative Effectiveness of Osteoporosis Drugs in Preventing Secondary Non-vertebral Fractures in Taiwanese Women (J Clin Endocrinol Metab)
12/03/2013	COMPARISON OF ALENDRONATE AND RALOXIFENE FOR THE MANAGEMENT OF PRIMARY HYPERPARATHYROIDISM (J Endocrinol Invest)
12/02/2013	Panostotic expansile bone disease with massive jaw tumor formation and a novel mutation in the signal peptide of RANK (J Bone Miner Res)
11/28/2013	Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With Alendronate: A Randomized Placebo-Controlled Trial (J Clin Endocrinol Metab)
11/15/2013	Osteoporosis drugs in real-world clinical practice: an analysis of persistence (Aging Clin Exp Res)
11/12/2013	The effect of the cathepsin K inhibitor ONO-5334 on trabecular and cortical bone in postmenopausal osteoporosis: The OCEAN study (J Bone Miner Res)
10/23/2013	Systematic review and meta-analysis of the efficacy and safety of alendronate and zoledronate for the treatment of postmenopausal osteoporosis (Gynecol Endocrinol)

1 2 3 4 5 6 7 8 9 10 Next